PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis

Abstract excerpt

Germline PTEN pathogenic variants cause a spectrum of disorders collectively labeled PTEN Hamartoma Tumor Syndrome (PHTS) and featured by hamartomas, developmental anomalies and increased cancer risk. Studies on experimental models provided evidence that PTEN is a “haploinsufficient” tumor-suppressor gene, however, mechanisms involved in the pathogenesis of clinical manifestations in PHTS patients remain elusive....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer and Skin Lesions
• Share to Infectious Diseases and Mycology
• Share to PI3K/AKT/mTOR signaling in cancer